Zevra Therapeutics (ZVRA) Other Working Capital Changes (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Other Working Capital Changes of -$123000.0 for Q1 2026, up 4.65% on a QoQ basis from -$129000.0 in Q4 2025, and down 121.96% year-over-year from $560000.0 in Q1 2025.
Zevra Therapeutics (ZVRA) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Zevra Therapeutics' Other Working Capital Changes history runs 11 years deep, the most recent figure standing at -$123000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 121.96% year-over-year to -$123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.4 million (down 2221.88% YoY) and the FY2025 annual result came in at -$675000.0, down 7.83% from the prior year.
- Other Working Capital Changes was -$123000.0 for Q1 2026 at Zevra Therapeutics, up from -$129000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.0 million in Q3 2025 and bottomed at -$703000.0 in Q1 2023.
- A 5-year average of $352941.2 and a median of -$125000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes tumbled 1139.09% — and 2025, when it surged 530.77%.
- Zevra Therapeutics' Other Working Capital Changes stood at $127000.0 in 2022, then plunged by 188.98% to -$113000.0 in 2023, then jumped by 458.41% to $405000.0 in 2024, then slumped by 131.85% to -$129000.0 in 2025, then rose by 4.65% to -$123000.0 in 2026.
- Business Quant data shows ZVRA's Other Working Capital Changes at -$123000.0 in Q1 2026, -$129000.0 in Q4 2025, and -$2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87,000.00 |
| Mar 31, 2026 | 87,000.00 |
| Mar 31, 2026 | 87,000.00 |
| Dec 31, 2025 | -399,000.00 |
| Dec 31, 2025 | -399,000.00 |
| Dec 31, 2025 | -399,000.00 |
| Sep 30, 2025 | 3.05 Mn |
| Sep 30, 2025 | 3.05 Mn |
| Sep 30, 2025 | 3.05 Mn |
| Jun 30, 2025 | 582,000.00 |
| Jun 30, 2025 | 582,000.00 |
| Jun 30, 2025 | 582,000.00 |
| Mar 31, 2025 | -286,000.00 |
| Mar 31, 2025 | -286,000.00 |
| Mar 31, 2025 | -286,000.00 |
| Dec 31, 2024 | 1.78 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | -410,000.00 |
| Sep 30, 2024 | -410,000.00 |